Show simple item record

Skin autofluorescence of advanced glycation end-products, glycemic memory, and diabetes complications.

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRIGALLEAU, Vincent
IDREF: 069788146
dc.contributor.authorPUCHEUX, Yann
dc.contributor.authorCOUFFINHAL, Thierry
dc.contributor.authorTESSIER, Frederic J
dc.contributor.authorHOWSAM, Michael
dc.contributor.authorRUBIN, Sébastien
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorHELMER, Catherine
dc.contributor.authorALKHAMI, Fadi
dc.contributor.authorLARROUMET, Alice
dc.contributor.authorBLANCO, Laurence
dc.contributor.authorBARBET-MASSIN, Marie-Amélie
dc.contributor.authorFERRIERE, Amandine
dc.contributor.authorMOHAMMEDI, Kamel
dc.contributor.authorFOUSSARD, Ninon
dc.date.accessioned2025-01-30T09:50:03Z
dc.date.available2025-01-30T09:50:03Z
dc.date.issued2024-12-06
dc.identifier.issn1878-1780en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/204658
dc.description.abstractEnSince the pionneer work of Meerwaldt and the Groningen team, who related skin autofluorescence (SAF) to the dermal concentrations of advanced glycation end-products (AGEs), hundreds of articles have been devoted to its application in diabetes. Due to the slow turnover of the AGEs formed on collagen of the skin, the SAF can reflect the progressive accumulation of AGEs and hence be a marker of long-term glucose exposure. Accordingly, relations with HbA1c from the previous 3-10 years have been established in both type 1 and type 2 diabetes, and even in gestational diabetes mellitus. Other important determinants of SAF exist however, notably age, renal function, diet, and genetics. SAF is also related to current and future micro- and macrovascular complications of diabetes, as expected for a marker of glycemic memory. It is also related to some important emerging diabetes complications and comorbidities such as cancer, cognitive decline and liver disease. Quantitative information on glucose exposure during the previous years may be pertinent to personnalize care for patients with diabetes: priority for glucose control when SAF is low, and for screening for complications once SAF is high.
dc.language.isoENen_US
dc.subject.enAdvanced glycation end-products
dc.subject.enDiabetes complications
dc.subject.enSkin autofluorescence
dc.title.enSkin autofluorescence of advanced glycation end-products, glycemic memory, and diabetes complications.
dc.title.alternativeDiabetes Metaben_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.diabet.2024.101600en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed39647777en_US
bordeaux.journalDiabetes & Metabolismen_US
bordeaux.page101600en_US
bordeaux.volume51en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamLEHA_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDSociété Francophone du Diabèteen_US
bordeaux.identifier.funderIDEuropean Foundation for the Study of Diabetesen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04920572
hal.version1
hal.date.transferred2025-01-30T09:50:07Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Diabetes%20&%20Metabolism&rft.date=2024-12-06&rft.volume=51&rft.issue=1&rft.spage=101600&rft.epage=101600&rft.eissn=1878-1780&rft.issn=1878-1780&rft.au=RIGALLEAU,%20Vincent&PUCHEUX,%20Yann&COUFFINHAL,%20Thierry&TESSIER,%20Frederic%20J&HOWSAM,%20Michael&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record